Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Viemed Healthcare
VMD
Viemed Healthcare
Medicare And Telehealth Pressures Will Dampen Prospects Yet Spur Resilience
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
29 May 25
Updated
23 Jul 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$11.00
33.4% undervalued
intrinsic discount
23 Jul
US$7.33
Loading
1Y
3.4%
7D
13.6%
Author's Valuation
US$11.0
33.4% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$11.0
33.4% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
332m
2014
2017
2020
2023
2025
2026
2028
Revenue US$331.8m
Earnings US$29.5m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
11.28%
Healthcare Services revenue growth rate
0.28%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$29.54m
Earnings '28
x
18.39x
PE Ratio '28
=
US$543.31m
Market Cap '28
US$543.31m
Market Cap '28
/
41.69m
No. shares '28
=
US$13.03
Share Price '28
US$13.03
Share Price '28
Discounted to 2025 @ 6.40% p.a.
=
US$10.82
Fair Value '25
